About the Event
Join the American Medical Informatics Association (AMIA) for an in-person policy forum exploring Human-in-the-Loop (HITL) and Human Oversight as approaches to clinical AI oversight and governance that strengthens safety, accountability, and trust while supporting innovation. This event convenes AMIA members, federal agency leaders and Congressional staff, and patients to examine how human judgment can be embedded by design across the AI lifecycle, from model development to real-world clinical use.

Why Defining the Role of Humans Matters
Over the past several years, humans have increasingly relied on AI tools in our everyday lives. Given the national clinician shortages and increasing clinical documentation times, both clinicians and patients have much to gain from the potential of AI to make care more efficient and accessible, allowing the use of AI in healthcare contexts mainstream. AMIA’s position on AI in clinical decision support (CDS) is that its use is neither good nor bad, it’s simply neutral. AI is a tool that can be used appropriately, supporting provision of and access to care, or it can be a tool that is used poorly, resulting in unintended consequences due to misuse, badly trained models, performance degradation, and distrust in the models. Human oversight accounts for the humanity needed in patient care. AI can optimize prediction, but without human involvement, healthcare loses its primary safety mechanism: contextual judgment under uncertainty.

Event Fee
AMIA Members: $100
Key Policy Questions
Why AMIA is Convening This Event
AMIA is convening this event to ensure that federal policymakers hear directly from the informatics experts who design, implement, and evaluate clinical AI in "real world" healthcare settings and the patients whose health is affected by them. By bringing AMIA members and our patient partners together with Capitol Hill staff and federal agencies—including ONC and CMS—this forum creates a timely opportunity to inform policy conversations, strengthen relationships, and advance practical oversight approaches that protect patients while supporting innovation. AMIA’s goal is to equip its members to engage confidently and credibly in federal AI discussions at a pivotal moment for healthcare policy.